Pharmacokinetics of tamoxifen in premenopausal and postmenopausal women with breast cancer
- 30 November 1995
- journal article
- research article
- Published by Elsevier in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 55 (2) , 229-231
- https://doi.org/10.1016/0960-0760(95)00169-z
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring.Journal of Clinical Oncology, 1993
- Breast Cancer Prevention Study Initiated in ItalyJNCI Journal of the National Cancer Institute, 1992
- Nearly 3,000 Randomized in North American Prevention TrialJNCI Journal of the National Cancer Institute, 1992
- Weight gain after primary surgery for breast cancer - effect of tamoxifenBreast Cancer Research and Treatment, 1992
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapyThe Lancet, 1992
- Identification of the cytochrome P450 IIIA family as the enzymes involved in the N-demethylation of tamoxifen in human liver microsomesBiochemical Pharmacology, 1991
- Hepatic Drug Metabolism and AgingClinical Pharmacokinetics, 1990
- Prevention of breast cancer with tamoxifen—an update on the royal Marsden Hospital pilot programmeEuropean Journal of Cancer and Clinical Oncology, 1990
- Tamoxifen metabolism: pharmacokinetic and in vitro studyBritish Journal of Cancer, 1989
- Tamoxifen antiestrogens. A comparison of the activity, pharmacokinetics, and metabolic activation of the cis and trans isomers of tamoxifenThe Journal of Steroid Biochemistry and Molecular Biology, 1982